NOVEN REPORTS POSITIVE PHASE 2 RESULTS FOR MESAFEM™ NON-HORMONAL THERAPY FOR VASOMOTOR SYMPTOMS Miami, FL – July 14, 2009 – Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced positive top-line results from - Hormonal therapy - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2013-06-27 13:50:45		NOVEN REPORTS POSITIVE PHASE 2 RESULTS FOR MESAFEM™ NON-HORMONAL THERAPY FOR VASOMOTOR SYMPTOMS Miami, FL – July 14, 2009 – Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced positive top-line results from Add to Reading List Source URL: www.noven.com Download Document from Source Website File Size: 235,85 KB Share Document on Facebook